SCHEMBL29888273

SCHEMBL29888273

CCC1(C(=O)N(N)C(=O)c2cccnc2Nc2ccc(C(F)(F)F)cc2)CCNC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.41
▸ KDR P35968 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ DHODH Q02127 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GMNN O75496 1/20 0.39
▸ TTR P02766 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ UGT1A1 P22309 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ PMP22 Q01453 1/20 0.39
▸ TEAD4 Q15561 1/20 0.39
▸ HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23389117 1.00 POLB (0.41) POLBKDRLMNADHODHMEN1
SCHEMBL23388911 0.88 RAB9A (0.37) POLBLMNADHODHMEN1ALDH1A1
SCHEMBL29888546 0.83 KDR (0.44) POLBKDRLMNADHODHMEN1
SCHEMBL23388897 0.83 KDR (0.44) POLBKDRLMNADHODHMEN1
SCHEMBL23389045 0.78 LMNA (0.43) POLBKDRLMNADHODHMEN1
SCHEMBL29888559 0.78 LMNA (0.43) POLBKDRLMNADHODHMEN1
SCHEMBL23388914 0.74 JAK2 (0.39) DHODHTRPV1MAPTJAK2JAK1
SCHEMBL23423434 0.73 LMNA (0.46) POLBKDRLMNADHODHMEN1
SCHEMBL23388931 0.73 MAPK8 (0.38) MEN1KMT2APTGS1RAB9AMAPT
SCHEMBL29888533 0.71 MEN1 (0.38) POLBKDRLMNADHODHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4061364-A1 HETEROARYL COMPOUNDS Vivace Therapeutics, Inc. (US) 2022-09-28 — — EP disclosed
Send feedback